Turkey TİTCK ÜTS Medical Device Registry Teardown: Database Analysis

Turkey Medical Device Registry Teardown

For medical device and in vitro diagnostic (IVD) manufacturers targeting expansion in Eurasia and the Middle East, Turkey represents a major, strategically located G20 market of approximately 85 million people. With a regulatory framework fully harmonized with European Union standards—including the adoption of the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Medical Device Regulation (EU IVDR)—Turkey offers a streamlined entry point for manufacturers who already hold CE marking.

However, registering a device in Turkey involves navigating the Turkish Medicines and Medical Devices Agency (TİTCK) and its sophisticated national database, the Product Tracking System (Ürün Takip Sistemi - ÜTS). Unlike typical emerging market databases, the ÜTS functions as both a pre-market registry and a post-market track-and-trace system, tracking every individual medical device from manufacturing or import to its final clinical use.

A quantitative teardown of the compiled ÜTS registry data (snapshot compiled in late June 2026) reveals several key structural metrics:

• Total Official Registrations: 5,783,008 device records are registered under the urunTipi_TIBBI_CIHAZ (medical device) classification in the TİTCK database.
• Application Outcome Split: Analysis of a representative 169,999-row database extract reveals that 137,276 records (80.8%) are active and fully registered (KAYITLI), 31,382 records (18.5%) are rejected (REDDEDILDI), and 1,341 records (0.8%) are deleted or deactivated (SILINDI).
• The 1-in-5 Rejection Rate: Approximately 18.5% of all submitted device registration records in the ÜTS database are rejected by TİTCK evaluators, indicating a significant administrative and technical barrier for applicants.
• Risk-Class Distribution: The Turkish registry is heavily dominated by low-risk devices. Class I other (non-sterile, non-measuring, non-reusable) leads with 110,580 records (65.0%), followed by Class IIb with 23,911 (14.1%), Class IIa with 14,947 (8.8%), Class III with 12,240 (7.2%), Class I reusable with 4,572 (2.7%), In Vitro Diagnostics (IVD) with 1,972 (1.2%), and Class I sterile with 1,083 (0.6%).
• Domestic vs. Import Split (IMAL vs. ITHAL): Unusually for an emerging or EU-adjacent market, the register is heavily weighted toward domestic production. 111,063 records (65.3%) are classified as domestically manufactured (IMAL), while only 58,936 records (34.7%) are imported (ITHAL).
• Single-Use Shares: Single-use devices account for 46,457 records (27.3%) of the analyzed register, representing a major segment of both domestic production and imports.

This teardown sizes the Turkish medical device register, breaks down its risk-class distribution, evaluates the domestic-vs-import competitive landscape, and analyzes the high rejection rate. For a step-by-step walkthrough of the regulatory requirements, please refer to our Turkey TİTCK registration process guide. To understand how this fits into a broader global strategy, consult our analysis of how CE/FDA dual approval multiplies accessible markets. For companies evaluating digital health and AI software, we compare digital-health and AI device rules across SFDA, EDA and TİTCK.

Methodology Note: This quantitative teardown is based on a representative 169,999-row random sample extracted from the official TİTCK ÜTS public citizen query portal (Ulusal Takip Sistemi) as of June 2026, restricted to the TIBBI_CIHAZ (medical device) product type. The official total count of active registrations is derived from the official durum_KAYITLI summary endpoint. Status outcomes, risk classes, single-use flags, and import/domestic splits are calculated directly from the representative dataset sample using automated text aggregation tools.

Turkey's Regulatory Framework: TİTCK and the ÜTS Track-and-Trace System

The Turkish regulatory system is governed by TİTCK (Türkiye İlaç ve Tıbbi Cihaz Kurumu), a division of the Ministry of Health. TİTCK regulates medicines, medical devices, cosmetics, and biocidal products.

Turkey's approach to medical devices is unique because it is fully integrated into the European regulatory framework while retaining national sovereignty over database tracking. The key elements of this framework include:

1. EU MDR and IVDR Alignment: Turkey has transposed the European Medical Devices Regulation (EU 2017/745) and the In Vitro Diagnostic Medical Devices Regulation (EU 2017/746, EU IVDR) into national law. Devices that comply with EU regulations and carry a valid CE mark can be imported into Turkey. TİTCK does not perform an independent clinical or technical review of the device if a CE certificate from an EU Notified Body is present; instead, it performs a document compliance review and registry notification.
2. The ÜTS (Ulusal Takip Sistemi) Database: The ÜTS is a comprehensive online tracking system developed in collaboration with TÜBİTAK (The Scientific and Technological Research Council of Turkey). The ÜTS serves two primary purposes:
   • Pre-Market Registration: Every medical device must be registered in ÜTS before it can be cleared for import, customs, or sale. The registration links the product's Global Trade Item Number (GTIN/Barcode) to its regulatory files, Notified Body certificate, Declaration of Conformity (DoC), and Instructions for Use (IFU).
   • Post-Market Track-and-Trace: Every single unit of a medical device imported or manufactured in Turkey is tracked by its barcode and serial/lot number. Importers and manufacturers must notify the ÜTS when a device is manufactured or imported, when it is transferred to a distributor, when it is sold to a hospital, and when it is consumed/used on a patient. This provides 100% traceability and helps prevent counterfeiting, theft, and grey-market imports.
3. Mandatory Turkish Authorized Representative (Temsilci): Foreign manufacturers cannot register their products in the ÜTS directly. They must appoint a local Turkish Authorized Representative (Authorized Representative - AR). The AR must be a legally registered entity in Turkey, holding a valid establishment license in the ÜTS, and must take full legal and regulatory responsibility for the devices in the Turkish market.
4. Barcodes and GS1 Standards: The ÜTS relies entirely on GS1 standards. Every device must have a unique GTIN. During registration, the manufacturer's GS1 barcode details are verified against the global GS1 registry. If the barcode is invalid or registered to a different company name, the ÜTS registration will be blocked.

How large is the Turkey ÜTS medical device register and what is its active-vs-rejected split?

The official TİTCK ÜTS register contains 5,783,008 active, registered medical device records (KAYITLI status) as of late June 2026. This massive volume reflects the fact that every individual package size, configuration, and private-label variant requires its own unique barcode and registration record in the system.

To evaluate application throughput and decision patterns, we analyzed a representative sample of 169,999 records containing both active, rejected, and deleted entries. The status distribution of this sample is detailed below:

The data shows that 18.5% of all submitted registration records are rejected. This means that nearly one in five product registration files fails to pass TİTCK's entry checks.

This high rejection rate is a critical finding for international regulatory teams. It shows that although Turkey recognizes the CE mark, the ÜTS notification process is far from a simple administrative "rubber stamp." TİTCK evaluators are highly meticulous and frequently reject applications for minor discrepancies.

Common Drivers of TİTCK ÜTS Rejections

Based on our analysis of TİTCK guidelines and distributor feedback, rejections are primarily driven by four factors:

1. Translation and Labeling Discrepancies: All user-facing documents, packaging labels, and Instructions for Use (IFUs) must be fully translated into Turkish. If the Turkish translation deviates from the original CE-approved English/European text, or if the translated IFU is missing key safety warnings, the file is rejected.
2. Notified Body and CE Certificate Validation: TİTCK verifies the validity of the underlying CE certificate directly with the issuing Notified Body or via the EUDAMED database. If the CE certificate has expired, is suspended, or does not explicitly cover the specific GTIN/model being registered, the system flags a rejection.
3. Barcode/GTIN Mismatches: If the GTIN provided in the ÜTS does not match the GS1 database registry, or if the product barcode printed on the packaging does not match the electronic submission file, the application is rejected.
4. Local Representative Authorization: If the relationship between the foreign manufacturer and the Turkish Authorized Representative is not properly documented with a notarized and apostilled Power of Attorney (POA), or if the POA has expired, the registration is rejected.

How is the Turkish register distributed across risk classes, and what does the Class-I dominance mean?

The ÜTS register classifies devices according to the standard European risk classification framework. The distribution of risk classes in the representative sample of 169,999 records is detailed in the table below:

Note: Counts are computed against the full 169,999-record sample; ~694 additional records (≈0.4%) fall into minor sub-classes (e.g., Class I measuring SINIF_I_M) that are not broken out as separate rows, so the column counts sum to 169,305.

This risk-class distribution reveals several key market insights:

1. Overwhelming Class I Dominance: Together, Class I categories (General, Reusable, and Sterile) account for 68.3% of the register. This shows that the volume of low-risk consumables, basic surgical instruments, and medical textiles dwarfs all other categories combined.
2. Strong Class IIb and Class III Foothold: Class IIb and Class III devices account for 21.3% of the database (over 36,000 records in the sample alone). This represents a highly sophisticated segment of high-tech devices, active monitors, implants, and life-support equipment.
3. The Implication for High-Risk Entrants: Because Class III and Class IIb devices involve complex clinical technologies, they face the highest level of scrutiny during customs clearance and ÜTS tracking. Importers of these devices must maintain perfect traceability and ensure that their local representative has the clinical training required to manage post-market vigilance for high-risk equipment.

Why is Turkey 65% domestically manufactured, and what does that mean for importers?

An analysis of the ithalImalBilgisi field (import vs. domestic information) in the representative registry sample reveals a striking finding:

• IMAL (Domestic Manufacture): 111,063 records (65.3%)
• ITHAL (Imported): 58,936 records (34.7%)

Unusually for an emerging market with a CE-harmonized regulatory system, nearly two-thirds of the registered medical device database consists of locally manufactured products.

This domestic dominance is driven by a combination of Turkish industrial policy, local market structures, and currency dynamics:

1. The Turkish Medical Manufacturing Hub: Turkey has developed a highly competitive domestic manufacturing sector centered around Istanbul, Izmir, and Samsun (the Samsun Medical Devices Industrial Zone is a major cluster). Local companies excel at producing low-risk medical consumables, surgical drapes, hospital furniture, syringes, sterilization wraps, orthopedic implants, and basic dental instruments.
2. "Localization" Procurement Incentives: The Turkish government actively promotes local manufacturing through procurement advantages. In public hospital tenders managed by the State Supply Office (DMO) or the Social Security Institution (SGK), locally manufactured products (defined as holding a "Yerli Malı Belgesi" or Domestic Goods Certificate) receive an automatic 15% price preference over imported competitors.
3. Currency and Cost Pressures: The depreciation of the Turkish Lira (TRY) against the Euro and USD has made imported products significantly more expensive for Turkish public hospitals. Local manufacturers, operating with Lira-denominated labor and facility costs, can offer basic consumables at prices that foreign importers cannot match.

What This Means for Foreign Importers

The 65% domestic share means that foreign manufacturers must segment the Turkish market carefully:

• Avoid Head-to-Head Class I Competition: Entering the Turkish market with imported, basic Class I consumables (e.g., standard syringes, bandages, simple surgical drapes) is rarely commercially viable. Local manufacturers dominate these segments on price, and the 15% tender preference makes public procurement almost inaccessible.
• Target High-Technology Gaps: Foreign importers should focus on Class IIb, Class III, and advanced IVD segments. Turkey remains highly dependent on imports for advanced capital equipment, robotic surgery systems, active implantable devices, specialized cardiac stents, and high-throughput laboratory diagnostic platforms. In these segments, clinical superiority and Notified Body backing outweigh local price advantages.

How long is a ÜTS registration valid, and what triggers renewal?

Unlike registries in Latin America or the Middle East that enforce fixed 5-year expiration cycles, ÜTS medical device registration has no fixed expiration date. Instead, the registration's validity is directly tied to the validity of the underlying CE certificate and the local relationship documents:

1. CE Certificate Validity: An ÜTS registration remains valid only as long as the underlying CE certificate (MDR or MDD transition certificate) remains valid. When the CE certificate is renewed, suspended, or updated by the Notified Body in Europe, the Turkish importer must immediately upload the new certificate to the ÜTS. If a CE certificate expires, all associated product registrations in the ÜTS are automatically suspended, blocking customs clearance and sales.
2. Declaration of Conformity (DoC): For Class I devices (non-sterile, non-measuring, non-reusable) that do not require a Notified Body certificate, the registration is tied to the manufacturer's self-declared Declaration of Conformity. If the manufacturer updates the DoC, the Turkish Representative must update the ÜTS entry.
3. Power of Attorney (POA) Validity: The POA authorizing the Turkish Representative must be updated according to the contract's term limits. If the POA expires, the representative's access to the ÜTS file is blocked.
4. Notified Body Certificate Transition (MDR/IVDR): With the transition from EU MDD/IVDD to MDR/IVDR, manufacturers must ensure their transition certificates or new MDR CE certificates are uploaded to the ÜTS to maintain active status.

The Role of the Turkish Authorized Representative (AR) and Transfer Rules

Because foreign manufacturers cannot access the ÜTS directly, the choice of a Turkish Authorized Representative is a critical strategic decision. The AR acts as the legal liaison with TİTCK and the Ministry of Health.

Key responsibilities of the Turkish AR include:

• ÜTS System Entry: Uploading technical files, CE certificates, translation files, and GTIN details.
• Customs Clearance Support: Verifying registrations at the border to allow import clearance.
• Vigilance and Tecnovigilancia: Reporting adverse events, managing field safety corrective actions (FSCAs), and coordinating recalls within Turkey.
• Barcoding and Track-and-Trace: Generating the electronic notification in ÜTS when a shipment arrives at the warehouse, and managing the transfer of unit-level tracking to distributors.

The Risk of Representative Lock-In

In Turkey, the ÜTS registration file belongs to the local representative who uploaded it. If a foreign manufacturer decides to change their distributor or representative, they face a potential "lock-in" risk:

• Transfer of Rights: Under TİTCK rules, a registration can only be transferred to a new representative if the current representative signs a digital "transfer of rights" (yetki devri) in the ÜTS portal.
• The Dispute Risk: If the relationship with the local distributor ends on bad terms, the distributor may refuse to sign the transfer. In this scenario, the foreign manufacturer cannot import their products through a new partner. The manufacturer's only recourse is to register the products entirely from scratch under new GTINs/barcodes, which is time-consuming, expensive, and requires changing the physical packaging barcodes.
• Strategic Advice: Manufacturers should separate their regulatory representative from their commercial distributor. By appointing an independent, third-party professional Authorized Representative to hold the ÜTS registrations, the manufacturer retains control over the registry and can easily appoint or change multiple commercial distributors without registration disruption.

Public Healthcare Procurement and Tenders (DMO and SGK)

The public sector is the dominant buyer of medical devices in Turkey, representing an estimated 60–65% of total medical-device procurement volume (with public-sector healthcare spend overall closer to ~75–79% of all health expenditure). Public procurement is managed through two main channels:

1. Public Hospitals (Ministry of Health): Individual hospitals or regional hospital unions procure devices through public tenders. These tenders are governed by Public Procurement Law No. 4734.
2. The State Supply Office (Devlet Malzeme Ofisi - DMO): The DMO acts as the central procurement agency for the Ministry of Health. It operates an online "Health Market" (Sağlık Marketi) portal, where standard medical consumables and equipment are purchased in bulk through electronic auctions.

Key Procurement Rules for Importers

• Mandatory ÜTS Registration: No medical device can participate in a public tender or be purchased by a public hospital unless it is fully registered and active (KAYITLI) in the ÜTS database.
• Reimbursement Code (SUT Code): The Social Security Institution (SGK) maintains the Health Implementation Communiqué (Sağlık Uygulama Tebliği - SUT), which lists the reimbursement codes and maximum price caps for medical procedures and associated devices. The ÜTS registration must be linked to the correct SUT code to ensure that the hospital can claim reimbursement for using the device.
• Domestic Preference Policy: As noted, Turkish-made devices receive a mandatory 15% price preference in public tenders, making cost-efficiency critical for imported products.

Comparative Analysis: Turkey vs. Regional Competitors

To assist regulatory and business development teams in regional planning, the table below compares Turkey's TİTCK ÜTS framework with its regional peers in Saudi Arabia (SFDA) and Egypt (EDA):

This comparison highlights that Turkey is the most integrated into the European system and features the most demanding post-market tracking system (unit-level ÜTS), alongside a notable record-level rejection rate (18.5% in the ÜTS sample) driven by strict barcode, CE-certificate, and document validation checks.

Strategic Market-Entry Playbook for Turkey

For regulatory affairs managers planning entry or expansion in Turkey, we recommend the following structured approach:

Step 1: Secure European MDR/IVDR Compliance

Before attempting ÜTS registration, ensure your product has a valid MDR CE certificate or is covered by the official EU MDR transition extensions. Turkey enforces European standards exactly; without a valid CE certificate or valid DoC for Class I, entry is blocked.

Step 2: Establish the Authorized Representative Structure

Avoid appointing a commercial distributor as your sole ÜTS registration holder. Work with an independent, professional Turkish Authorized Representative who holds the registrations, and then license the sales rights to local commercial distributors. This protects your market freedom and avoids representative lock-in.

Step 3: Perform a Pre-Submission Barcode & GS1 Audit

Ensure all product GTINs are fully registered and active in the global GS1 database. The company name on the GS1 registry must match the manufacturing entity named on the CE certificate. Any mismatch will cause an automatic rejection in the ÜTS portal.

Step 4: Budget for Turkish Translation and Labeling

All packaging labels, user manuals, and software interfaces must be translated into Turkish by professional translators who understand medical device terminology. Ensure the Turkish IFU is a faithful translation of the CE-approved file to prevent evaluator rejections.

Step 5: Map Tender Opportunities and SUT Reimbursement

Work with your local partners to identify the correct SUT reimbursement codes for your products. If no SUT code matches your device, evaluate the pathway for establishing a new code or target private hospital segments that do not rely on public reimbursement.

Frequently Asked Questions (FAQ)

Is Turkey part of the EU MDR?

Yes, Turkey is not an EU member state, but it is part of the EU Customs Union and has fully aligned its medical device regulations with the EU MDR (2017/745) and IVDR (2017/746). CE-marked devices are accepted in Turkey.

Does Turkey require a CE mark to register a medical device in ÜTS?

Yes, a valid CE mark and associated documentation (Declaration of Conformity, Notified Body Certificate if applicable) are mandatory for registering any medical device or IVD in the ÜTS database.

Do foreign manufacturers need a local Authorized Representative in Turkey?

Yes, foreign manufacturers must appoint a local Turkish Authorized Representative (AR) who holds the ÜTS registration, represents the manufacturer before TİTCK, and manages the track-and-trace notifications for imported devices.